Science asks authors to retract XMRV-chronic fatigue syndrome paper; when they refuse, issue Expression of Concern

It’s Expression of Concern Day here at Retraction Watch. Earlier, we reported on two such notices regarding the complicated case of Milena Penkowa. And now we learn that a 2009 Science paper linking XMRV, or xenotropic murine leukemia-related virus, to chronic fatigue syndrome  (CFS) that has been dogged by questions from the start, is the subject of another Expression of Concern. Such expressions, as we’ve noted, often, but do not always, precede retractions.

The Wall Street Journal reports that Science editor-in-chief Bruce Alberts and executive editor Monica Bradford asked the authors of the paper to retract it last week, after two studies scheduled to published in this week’s Science threw even more doubt onto the findings. But “study co-author Judy A. Mikovits of the Whittemore Peterson Institute for Neuro-Immune Disease said “it is premature to retract our paper,” leading Alberts to issue the Expression of Concern, which begins: Continue reading Science asks authors to retract XMRV-chronic fatigue syndrome paper; when they refuse, issue Expression of Concern

Expressions of Concern arrive in Milena Penkowa case

The scientific literature has started to hint at the fallout of a case of potential fraud in Denmark. As Nature reported in January:

A high-profile neuroscientist in Denmark has resigned after facing allegations that she committed research misconduct and misspent grant money. Meanwhile, the administration at the university where she worked has been accused of ignoring her alleged misdeeds for the better part of a decade.

Milena Penkowa, a 37-year-old researcher who was lauded in 2009 by the Danish science ministry, denies all the accusations against her and stands by her work, but left her post as a full professor at the University of Copenhagen in December.

Penkowa has published about 100 papers, many of them focused on neuroscience and a family of proteins known as metallothioneins. While the investigation into her lab continues, two journals have published Expressions of Concern about Penkowa’s work: Continue reading Expressions of Concern arrive in Milena Penkowa case

Our computer ate the data: Expression of concern over blood thinner study raises concerns itself

Thrombosis and Haemostasis has issued an “expression of concern” over a 2004 paper by Tunisian researchers:

Concerns have been raised by readers about the accuracy and validity of the data reported in the September 2004 article by Abdelkefi et al., entitled “Prevention of central venous line-related thrombosis by continuous infusion of low-dose unfractionated heparin, in patients with haemato-oncological disease. A randomized controlled trial” (Abdelkefi A et al.Thromb Haemost 2004; 92: 654–661).

In the trial, 108 patients with blood cancers reportedly received infusions of either saline or heparin, a blood thinner. Those given the active drug were far less likely to develop clots related to their catheters, according to the researchers, and no more likely to experience severe bleeding. In the report, the researchers write:

This is the first prospective, randomized study, which shows that low-dose of unfractionated heparin is safeand effective to prevent catheter-related thrombosis in patients with haemato-oncological disease.

The article has had an impact, having been cited 32 times, according to Thomson Scientific’s Web of Knowledge. At some point after publication, however, the results evidently began to look fishy. Again from the journal: Continue reading Our computer ate the data: Expression of concern over blood thinner study raises concerns itself